Predicting reproductive age with biomarkers of ovarian reserve-how (and what) are we measuring?

Seminars in Reproductive Medicine

Volumn 31, Issue 6, 2013, Pages 416-426

  Hansen, Karl R ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

anti M llerian hormone; antral follicle count; nongrowing follicles; ovarian reserve; primordial follicles

Indexed keywords

ANDROGEN; BIOLOGICAL MARKER; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

AGE; AGING; ARTICLE; EARLY MENOPAUSE; ESTRADIOL BLOOD LEVEL; FAMILY PLANNING; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; OOCYTE; OVARIAN RESERVE; OVARY FOLLICLE; RISK ASSESSMENT; STAGING; ANIMAL; BIOLOGICAL MODEL; EVIDENCE BASED MEDICINE; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIMARY OVARIAN INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

AGING; ANIMALS; BIOLOGICAL MARKERS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MODELS, BIOLOGICAL; OVARY; PRIMARY OVARIAN INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 84885359306     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1356477     Document Type: Article

References (101)

1. te Velde E. R., Pearson P. L. The variability of female reproductive ageing. Hum Reprod Update: 2002; 8 2 141 154 (Pubitemid 34428965)
2. Leridon H. Demographic effects of the introduction of steroid contraception in developed countries. Hum Reprod Update: 2006; 12 5 603 616 (Pubitemid 44307835)
3. Matthews T. J., Hamilton B. E. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief: 2009; 21 21 1 8
4. Soules M. R.; American Society for Reproductive Medicine. The story behind the American Society for Reproductive Medicine's prevention of infertility campaign. Fertil Steril: 2003; 80 2 295 299 (Pubitemid 36959785)
5. van Wayenburg C. A., van der Schouw Y. T., van Noord P. A., Peeters P. H. Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort. Epidemiology: 2000; 11 3 304 308 (Pubitemid 30228199)
6. van Der Voort D. J., van Der Weijer P. H., Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int: 2003; 14 6 525 530 (Pubitemid 36919215)
7. van der Schouw Y. T., van der Graaf Y., Steyerberg E. W., Eijkemans J. C., Banga J. D. Age at menopause as a risk factor for cardiovascular mortality. Lancet: 1996; 347 9003 714 718 (Pubitemid 26085645)
8. Mondul A. M., Rodriguez C., Jacobs E. J., Calle E. E. Age at natural menopause and cause-specific mortality. Am J Epidemiol: 2005; 162 11 1089 1097 (Pubitemid 41746621)
9. Ossewaarde M. E., Bots M. L., Verbeek A. L., et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology: 2005; 16 4 556 562 (Pubitemid 40847843)
10. Monninkhof E. M., van der Schouw Y. T., Peeters P. H. Early age at menopause and breast cancer: are leaner women more protected? A prospective analysis of the Dutch DOM cohort. Breast Cancer Res Treat: 1999; 55 3 285 291 (Pubitemid 29425580)
11. Fries J. F. Aging, natural death, and the compression of morbidity. N Engl J Med: 1980; 303 3 130 135 (Pubitemid 10076605)
12. Treloar A. E. Menstrual cyclicity and the pre-menopause. Maturitas: 1981; 3 3-4 249 264 (Pubitemid 12145694)
13. Broekmans F. J., Soules M. R., Fauser B. C. Ovarian aging: mechanisms and clinical consequences. Endocr Rev: 2009; 30 5 465 493
14. Santoro N., Brown J. R., Adel T., Skurnick J. H. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab: 1996; 81 4 1495 1501 (Pubitemid 26118582)
15. Lambalk C. B., van Disseldorp J., de Koning C. H., Broekmans F. J. Testing ovarian reserve to predict age at menopause. Maturitas: 2009; 63 4 280 291
16. Weiss G., Skurnick J. H., Goldsmith L. T., Santoro N. F., Park S. J. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA: 2004; 292 24 2991 2996 (Pubitemid 39665300)
17. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev: 1996; 17 2 121 155 (Pubitemid 26119956)
18. Gougeon A. The early stages of follicular growth. In: Trounson A. O., Gosden R. G., eds. Biology and Pathology of the Oocyte: Role in Fertility and Reproductive Medicine. Cambridge Cambridge University Press: 2003; 29 41
19. Battaglia D. E., Goodwin P., Klein N. A., Soules M. R. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod: 1996; 11 10 2217 2222 (Pubitemid 26392017)
20. Munné S., Chen S., Colls P., et al. Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online: 2007; 14 5 628 634
21. Block E. Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat (Basel): 1952; 14 (1-2, Suppl 16): 108 123
22. Gougeon A., Chainy G. B. Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil: 1987; 81 2 433 442 (Pubitemid 17160422)
23. Faddy M. J., Gosden R. G., Gougeon A., Richardson S. J., Nelson J. F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod: 1992; 7 10 1342 1346 (Pubitemid 23042150)
24. Hansen K. R., Knowlton N. S., Thyer A. C., Charleston J. S., Soules M. R., Klein N. A. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod: 2008; 23 3 699 708 (Pubitemid 351651214)
25. Gundersen H. J., Bagger P., Bendtsen T. F., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS: 1988; 96 10 857 881
26. West M. J. New stereological methods for counting neurons. Neurobiol Aging: 1993; 14 4 275 285 (Pubitemid 23214693)
27. Wallace W. HB, Kelsey T. W. Human ovarian reserve from conception to the menopause. PLoS ONE: 2010; 5 1 e8772
28. Scott R. T., Toner J. P., Muasher S. J., Oehninger S., Robinson S., Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril: 1989; 51 4 651 654 (Pubitemid 19097780)
29. Toner J. P., Philput C. B., Jones G. S., Muasher S. J. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril: 1991; 55 4 784 791
30. Smotrich D. B., Widra E. A., Gindoff P. R., Levy M. J., Hall J. L., Stillman R. J. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril: 1995; 64 6 1136 1140
31. Frattarelli J. L., Bergh P. A., Drews M. R., Sharara F. I., Scott R. T. Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril: 2000; 74 3 518 524
32. Seifer D. B., Lambert-Messerlian G., Hogan J. W., Gardiner A. C., Blazar A. S., Berk C. A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril: 1997; 67 1 110 114 (Pubitemid 26428422)
33. Hall J. E., Welt C. K., Cramer D. W. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod: 1999; 14 2 409 415 (Pubitemid 29097396)
34. Tomas C., Nuojua-Huttunen S., Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod: 1997; 12 2 220 223 (Pubitemid 27129375)
35. Chang M-Y, Chiang C-H, Hsieh T-T, Soong Y-K, Hsu K-H. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril: 1998; 69 3 505 510
36. Frattarelli J. L., Lauria-Costab D. F., Miller B. T., Bergh P. A., Scott R. T. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril: 2000; 74 3 512 517
37. Bancsi L. FJMM, Broekmans F. JM, Eijkemans M. JC, de Jong F. H., Habbema J. DF, te Velde E. R. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril: 2002; 77 2 328 336 (Pubitemid 34083557)
38. Hansen K. R., Morris J. L., Thyer A. C., Soules M. R. Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril: 2003; 80 3 577 583 (Pubitemid 37102869)
39. van Rooij I. AJ, Broekmans F. J., te Velde E. R., et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod: 2002; 17 12 3065 3071 (Pubitemid 35469254)
40. Seifer D. B., MacLaughlin D. T., Christian B. P., Feng B., Shelden R. M. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril: 2002; 77 3 468 471 (Pubitemid 34177199)
41. Broer S. L., Mol B. W., Hendriks D., Broekmans F. J. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril: 2009; 91 3 705 714
42. Loumaye E., Billion J. M., Mine J. M., Psalti I., Pensis M., Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril: 1990; 53 2 295 301 (Pubitemid 20076359)
43. Tanbo T., Dale P. O., Lunde O., Norman N., Abyholm T. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels. Fertil Steril: 1992; 57 4 819 824
44. Padilla S. L., Bayati J., Garcia J. E. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril: 1990; 53 2 288 294 (Pubitemid 20076358)
45. Winslow K. L., Toner J. P., Brzyski R. G., Oehninger S. C., Acosta A. A., Muasher S. J. The gonadotropin-releasing hormone agonist stimulation test-a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril: 1991; 56 4 711 717
46. Broekmans F. J., Kwee J., Hendriks D. J., Mol B. W., Lambalk C. B. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update: 2006; 12 6 685 718 (Pubitemid 44605509)
47. Verhagen T. E., Hendriks D. J., Bancsi L. F., Mol B. W., Broekmans F. J. The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum Reprod Update: 2008; 14 2 95 100 (Pubitemid 351321105)
48. Sun W., Stegmann B. J., Henne M., Catherino W. H., Segars J. H. A new approach to ovarian reserve testing. Fertil Steril: 2008; 90 6 2196 2202
49. Scott R. T. Jr, Elkind-Hirsch K. E., Styne-Gross A., Miller K. A., Frattarelli J. L. The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone. Fertil Steril: 2008; 89 4 868 878 (Pubitemid 351491232)
50. Hansen K. R., Hodnett G. M., Knowlton N., Craig L. B. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril: 2011; 95 1 170 175
51. Sherman B. M., West J. H., Korenman S. G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab: 1976; 42 4 629 636
52. Reyes F. I., Winter J. S., Faiman C. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol: 1977; 129 5 557 564 (Pubitemid 8226857)
53. Klein N. A., Houmard B. S., Hansen K. R., et al. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab: 2004; 89 6 2977 2981 (Pubitemid 38766396)
54. Randolph J. F. Jr, Crawford S., Dennerstein L., et al. The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition. J Clin Endocrinol Metab: 2006; 91 8 3034 3040 (Pubitemid 44271752)
55. Harlow S. D., Gass M., Hall J. E., et al. STRAW+10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric: 2012; 15 2 105 114
56. Harlow S. D., Gass M., Hall J. E., et al. STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril: 2012; 97 4 843 851
57. Harlow S. D., Gass M., Hall J. E., et al. STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab: 2012; 97 4 1159 1168
58. Harlow S. D., Gass M., Hall J. E., et al. STRAW 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause: 2012; 19 4 387 395
59. Sowers M. R., Eyvazzadeh A. D., McConnell D., et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab: 2008; 93 9 3478 3483
60. Welt C., Sidis Y., Keutmann H., Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood): 2002; 227 9 724 752
61. Vale W., Rivier C., Hsueh A., et al. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res: 1988; 44 1 34
62. Weiss J., Crowley W. FJ Jr, Halvorson L. M., Jameson J. L. Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology: 1993; 132 6 2307 2311 (Pubitemid 23156876)
63. Groome N. P., Illingworth P. J., O'Brien M., et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab: 1996; 81 4 1401 1405 (Pubitemid 26119665)
64. Corson S. L., Gutmann J., Batzer F. R., Wallace H., Klein N., Soules M. R. Inhibin-B as a test of ovarian reserve for infertile women. Hum Reprod: 1999; 14 11 2818 2821 (Pubitemid 29520700)
65. Creus M., Peñarrubia J., Fábregues F., et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod: 2000; 15 11 2341 2346
66. Gracia C. R., Sammel M. D., Freeman E. W., et al. Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause: 2005; 12 2 128 135 (Pubitemid 40464279)
67. Burger H. G., Hale G. E., Robertson D. M., Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update: 2007; 13 6 559 565 (Pubitemid 350018524)
68. Scheffer G. J., Broekmans F. J., Dorland M., Habbema J. D., Looman C. W., te Velde E. R. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril: 1999; 72 5 845 851 (Pubitemid 29505448)
69. Rosen M. P., Sternfeld B., Schuh-Huerta S. M., Reijo Pera R. A., McCulloch C. E., Cedars M. I. Antral follicle count: absence of significant midlife decline. Fertil Steril: 2010; 94 6 2182 2185
70. Yang Y. S., Hur M. H., Kim S. Y., Young K. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition. Menopause: 2011; 18 2 138 145
71. Hansen K. R., Craig L. B., Zavy M. T., Klein N. A., Soules M. R. Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system. Menopause: 2012; 19 2 164 171
72. Hehenkamp W. J., Looman C. W., Themmen A. P., de Jong F. H., Te Velde E. R., Broekmans F. J. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab: 2006; 91 10 4057 4063 (Pubitemid 44536885)
73. Weenen C., Laven J. S., Von Bergh A. R., et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod: 2004; 10 2 77 83 (Pubitemid 38196508)
74. Fanchin R., Schonäuer L. M., Righini C., Guibourdenche J., Frydman R., Taieb J. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod: 2003; 18 2 323 327 (Pubitemid 36236265)
75. Hale G. E., Zhao X., Hughes C. L., Burger H. G., Robertson D. M., Fraser I. S. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab: 2007; 92 8 3060 3067 (Pubitemid 47236371)
76. van Rooij I. A., Broekmans F. J., Scheffer G. J., et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril: 2005; 83 4 979 987
77. Seifer D. B., Baker V. L., Leader B. Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States. Fertil Steril: 2011; 95 2 747 750
78. van Disseldorp J., Faddy M. J., Themmen A. PN., et al. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab: 2008; 93 6 2129 2134 (Pubitemid 351831526)
79. Kelsey T. W., Wright P., Nelson S. M., Anderson R. A., Wallace W. H. A validated model of serum anti-müllerian hormone from conception to menopause. PLoS ONE: 2011; 6 7 e22024
80. de Vet A., Laven J. S., de Jong F. H., Themmen A. P., Fauser B. C. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril: 2002; 77 2 357 362 (Pubitemid 34083560)
81. Tran N. D., Cedars M. I., Rosen M. P. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab: 2011; 96 12 3609 3614
82. de Boer E. J., den Tonkelaar I., te Velde E. R., Burger C. W., van Leeuwen F. E.; OMEGA-project group. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod: 2003; 18 7 1544 1552 (Pubitemid 36840968)
83. Lawson R., El-Toukhy T., Kassab A., et al. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod: 2003; 18 3 527 533 (Pubitemid 36329319)
84. Nikolaou D., Lavery S., Turner C., Margara R., Trew G. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod: 2002; 17 4 1106 1111 (Pubitemid 34411154)
85. Gülekli B., Bulbul Y., Onvural A., et al. Accuracy of ovarian reserve tests. Hum Reprod: 1999; 14 11 2822 2826 (Pubitemid 29520701)
86. Treloar A. E., Boynton R. E., Behn B. G., Brown B. W. Variation of the human menstrual cycle through reproductive life. Int J Fertil: 1967; 12 1, Pt 2 77 126
87. Taffe J. R., Dennerstein L. Menstrual patterns leading to the final menstrual period. Menopause: 2002; 9 1 32 40 (Pubitemid 34106162)
88. Mitchell E. S., Woods N. F., Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause: 2000; 7 5 334 349
89. Harlow S. D., Mitchell E. S., Crawford S., Nan B., Little R., Taffe J.; ReSTAGE Collaboration. The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition. Fertil Steril: 2008; 89 1 129 140
90. Taffe J. R., Cain K. C., Mitchell E. S., Woods N. F., Crawford S. L., Harlow S. D. "Persistenceo" improves the 60-day amenorrhea marker of entry to late-stage menopausal transition for women aged 40 to 44 years. Menopause: 2010; 17 1 191 193
91. Klein N. A., Harper A. J., Houmard B. S., Sluss P. M., Soules M. R. Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? J Clin Endocrinol Metab: 2002; 87 12 5746 5750 (Pubitemid 36034385)
92. Soules M. R., Sherman S., Parrott E., et al. Executive Summary: Stages of reproductive aging workshop (STRAW). Fertil Steril: 2001; 76 5 874 878 (Pubitemid 33031310)
93. Lass A. Assessment of ovarian reserve: is there still a role for ovarian biopsy in the light of new data? Hum Reprod: 2004; 19 3 467 469 (Pubitemid 38344501)
94. Broekmans F. J., Faddy M. J., Scheffer G., te Velde E. R. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause: 2004; 11 6, Pt 1 607 614 (Pubitemid 40353223)
95. van Rooij I. A., Tonkelaar Id, Broekmans F. J., et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause: 2004; 11 6, Pt 1 601 606 (Pubitemid 40353222)
96. Broer S. L., Eijkemans M. JC, Scheffer G. J., et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab: 2011; 96 8 2532 2539
97. Tehrani F. R., Shakeri N., Solaymani-Dodaran M., Azizi F. Predicting age at menopause from serum antimüllerian hormone concentration. Menopause: 2011; 18 7 766 770
98. Tehrani F. R., Solaymani-Dodaran M., Tohidi M., Gohari M. R., Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab: 2013; 98 2 729 735
99. Freeman E. W., Sammel M. D., Lin H., Gracia C. R. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab: 2012; 97 5 1673 1680
100. Freeman E. W., Sammel M. D., Lin H., Boorman D. W., Gracia C. R. Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women. Fertil Steril: 2012; 98 5 1254 1259, e1-e2
101. Gougeon A., Ecochard R., Thalabard J. C. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod: 1994; 50 3 653 663 (Pubitemid 24058526)